The best online tirzepatide provider for a particular person depends on the clinical assessment, exact product, pharmacy, cost, and ongoing care. A public website cannot settle those details for everyone.
This shortlist puts the full provider reviews beside their prices and continuation rules. We rechecked the featured offers on October 5, 2026 and keep older source dates visible in the individual notes. Start with the treatment and written commitment that fit your clinical discussion.
Use the order as a reading list. Let a qualified clinician assess treatment, and verify the actual prescription and service agreement.
1. CoreAge Rx
9.9/10
CoreAge’s supplied annual tirzepatide quote begins at $129 per month, or $1,548 for twelve months. Its public product page separately shows a $149 starting price. Clarify which selected offer covers your prescription and supply before comparing the complete bill.
The full CoreAge review follows assessment, pharmacy assignment and the policy’s consultation-fee, fulfillment and 30-day refund limits. Bring those terms to the same conversation as clinical suitability and follow-up.
Sources: CoreAge Rx: Tirzepatide product page · CoreAge Rx: Current promotional offer · CoreAge Rx: returns, refunds and subscription policy
2. SuperHealthy Rx
9.7/10
The linked promotion displays compounded tirzepatide at $135 per month, with visit, medication and shipping described as included. The FAQ says automatic refill is optional after the first order; the main site uses different starting-price language. Confirm the named offer and supplied quantity.
Read the SuperHealthy review for its conditional prescription and refund wording, the refill setting and the route for clinical questions. A low displayed rate does not establish an approved product or a guaranteed prescription.
Sources: SuperHealthy Rx: official glp offer · SuperHealthy Rx: main website · FDA: Concerns with unapproved GLP-1 drugs
3. Likeness Rx
9.5/10
Likeness’s tirzepatide cards pair $199 for one month with $477 for three, $834 for six and $1,548 for twelve. The longest term has a $129 monthly equivalent. The FAQ describes automatic selected-term renewal and an early first-refill charge.
The Likeness review keeps the total payment, included-care list and declined-prescription refund separate. Ask for order-specific cancellation and pharmacy instructions before relying on a cancel-anytime headline.
Sources: Likeness Rx — GLP-1 weight care · HHS: Licensing across state lines · FDA: Concerns with unapproved GLP-1 drugs
4. LillyDirect — an approved-product access route
LillyDirect describes self-pay access options for Zepbound, an FDA-approved tirzepatide product. Its public pricing starts at $299 for 2.5 mg, with other strength-specific prices and program conditions.
Confirm your prescription, presentation, supplies, and the current payment terms. Ask who provides clinical follow-up, because medicine access and continuing care are separate parts of the process. Our LillyDirect review explains the distinction without assuming the service fits every reader.
Sources: LillyDirect: Zepbound self-pay options · Lilly: Zepbound prescribing information
5. Mochi Health — examine the complete plan
Mochi describes virtual care with provider visits and messaging, plus plan-dependent support. Its FAQ lists a $79 one-month membership and compounded tirzepatide starting at $90 monthly, with medication prices changing by prescribed dose.
Ask for the combined cost and the support included in your chosen plan. Clarify the exact medicine and pharmacy rather than treating a medication directory as a promise of availability. Read the Mochi review, including its refund-policy discussion.
Sources: Mochi Health: Public care and pricing FAQs · Mochi Health: Medication directory · Mochi Health: Refunds
6. Remedy Meds — clarify the commitment
Remedy Meds is another service to investigate for compounded tirzepatide. Request a current written quote and read the renewal and warranty terms together. A cancellation option does not necessarily return fees for a term already paid.
Our Remedy Meds review, added September 24, 2026, also discusses FDA’s dated September 2025 marketing letter. Inclusion here does not establish current regulatory resolution, clinical quality, or suitability for a particular reader.
Sources: Remedy Meds: Terms of Service, June 4, 2026 · FDA: Remedy Meds warning letter, September 9, 2025
Apply the same checks to every service
Verify a legitimate prescription process, a clinician authorized to treat you, and the dispensing pharmacy’s relevant state license. Ask how the team handles side effects, refills, and interruptions. FDA’s online-pharmacy resources are useful for those checks.
If a compounded medicine is proposed, ask why an approved drug would not meet your medical needs. Compounded drugs are not FDA-approved, and FDA’s current tirzepatide compounding policy cannot be replaced by an old shortage claim on a sales page. Our compounding fieldnote explains the practical questions.
Sources: FDA: Buying medicines from online pharmacies · HHS: Licensing across state lines · FDA: Concerns with unapproved GLP-1 drugs · FDA: GLP-1 supply and compounding policy
Choose the next conversation, not a guaranteed result
This shortlist does not verify each prescriber, shipment, or patient outcome. Prices are public snapshots, and availability depends on the service, state, prescription, and patient. We do not use testimonials as evidence that one provider produces better results.
Take the visit notebook to a consultation and use the cost guide to request a complete estimate. A clear explanation of the product and care plan is a better basis for a decision than a universal best-provider label.
Sources: FDA: Managing medicine benefits and risks · NIDDK: Prescription medicines for overweight and obesity
The source shelf
- CoreAge Rx: Tirzepatide product page
Product page read October 5, 2026: $149 starting figure. The separate $129 annual quote was supplied to this publication; an individual checkout was not tested.
- CoreAge Rx: Current promotional offer
External offer link. The supplied $129 monthly equivalent concerns a 12-month tirzepatide quote ($1,548 total), not a claim that this page currently displayed that figure. Confirm selected checkout.
- CoreAge Rx: returns, refunds and subscription policy
Primary policy read October 5, 2026. Assessment fees, pharmacy transmission and a 30-day order cutoff limit refunds; policy execution was not tested.
- SuperHealthy Rx: official glp offer
Offer page read October 5, 2026: $135 tirzepatide, $85 semaglutide, optional automatic refill and conditional clinical-ineligibility refund language. Advertised terms, not tested service.
- SuperHealthy Rx: main website
Read October 5, 2026. The general starting-price language differs from the linked promotional offer; reconcile the selected checkout.
- FDA: Concerns with unapproved GLP-1 drugs
Current FDA page read October 5, 2026. Compounding, dose and ingredient concerns; individual medical need does not establish automatic eligibility or equivalence.
- Likeness Rx — GLP-1 weight care
GLP-1 plan cards and FAQ read October 5, 2026. Term prices, automatic renewal, early first-refill billing and a declined-prescription refund are provider statements; no order was placed.
- HHS: Licensing across state lines
The patient location affects telehealth licensure requirements; a place page does not verify a provider.
- LillyDirect: Zepbound self-pay options
Manufacturer page checked October 5, 2026: $299 starting self-pay figure for the starting strength, with presentation, supply-period, eligibility and refill-timing conditions. Not an all-strength price.
- Lilly: Zepbound prescribing information
Current manufacturer label read October 5, 2026: approved weight-management and moderate-to-severe OSA uses in specified adults; product-specific contraindications and instructions. Does not establish compounded-product equivalence.
- Mochi Health: Public care and pricing FAQs
FAQ checked October 5, 2026. $79 one-month membership and compounded tirzepatide from $90, dependent on dose; these are separate fees. Promotional membership offers may differ.
- Mochi Health: Medication directory
Product availability must be confirmed with a clinician; a catalog is not a personal prescribing decision.
- Mochi Health: Refunds
Cancellation and refund rules can differ for membership and a processed prescription.
- Remedy Meds: Terms of Service, June 4, 2026
Section 5: subscription terms, cancellation and conditional 12-month warranty. Checked September 24, 2026; read the terms accompanying the selected offer.
- FDA: Remedy Meds warning letter, September 9, 2025
Dated FDA finding about misleading compounded-product marketing. Read September 24, 2026; present resolution was not established.
- FDA: Buying medicines from online pharmacies
Checks for prescription requirements, licensing, contact details and pharmacy support.
- FDA: GLP-1 supply and compounding policy
Shortage resolution and restrictions on essentially copies; availability requires current professional assessment.
- FDA: Managing medicine benefits and risks
General questions for clinical decision-making and medication follow-up.
- NIDDK: Prescription medicines for overweight and obesity
Chronic weight-management decisions and ongoing lifestyle care.
